Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

10 Biotech Stocks With Big Potential Upside In 2012: Part III
Seeking Alpha
Thursday, February 16, 2012 - 5:21pm
tags:
Spectrum Pharmaceuticals, Questcor, ImmunoCellular
Fake Avastin may not be the only counterfeit on doctors' shelves
Fierce Pharma
Thursday, February 16, 2012 - 11:44am
tags:
Avastin, Roche, drug counterfeiting, Herceptin, Rituxan
Novartis Steps Up Investments in Taiwan
Taiwan Economic News
Thursday, February 16, 2012 - 11:43am
tags:
Novartis, Taiwan
Sandoz buys German rights to Apricus' sex drug
Reuters
Thursday, February 16, 2012 - 11:25am
tags:
Germany, Apricus Biosciences, Vitaros, Sandoz, Novartis
3 Highly Shorted Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Thursday, February 16, 2012 - 11:22am
tags:
Vivus, Seattle Genetics, Amyris
1-Star Stocks Poised to Plunge: Regeneron?
Motley Fool
Thursday, February 16, 2012 - 11:21am
tags:
Regeneron
2-Star Stocks Poised to Plunge: ISTA Pharmaceuticals?
Motley Fool
Thursday, February 16, 2012 - 11:21am
tags:
ISTA Pharmaceuticals
Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
Yahoo
Thursday, February 16, 2012 - 11:20am
tags:
Pfizer, Mylan, auto-injectors, settlements, Meridian Medical Technologies, e-cue
Why I'm A Near-Term Bear On These 4 Healthcare Stocks
Seeking Alpha
Thursday, February 16, 2012 - 11:19am
tags:
Abbott Laboratories, Merck, Pfizer, Boston Scientific
Alnylam climbs 16% on stock offer pricing
Marketwatch
Thursday, February 16, 2012 - 9:32am
tags:
stock offering, Alnylam
FTC ends review of Amgen's purchase of Micromet
Yahoo/AP
Thursday, February 16, 2012 - 9:31am
tags:
Amgen, Micromet, FTC, M&A
FDA Advisory Panel 101
Motley Fool
Thursday, February 16, 2012 - 9:31am
tags:
FDA, advisory panels
Avanir Pharmaceuticals: Nuedexta's First Birthday - Wiping Away The Tears
Seeking Alpha
Thursday, February 16, 2012 - 9:30am
tags:
Avanir, Nuedexta, PBA
AstraZeneca announces first direct-to-patient program offering ARIMIDEX
The Fly on the Wall
Thursday, February 16, 2012 - 9:29am
tags:
Arimidex, AstraZeneca, Express Scripts
J&J to Develop Spider Venom Pain Drug With Queensland University
Bloomberg
Thursday, February 16, 2012 - 9:28am
tags:
JNJ, pain management, chronic pain
FDA biosimilars guidance sparks reviews of IP protection
Mass High Tech
Wednesday, February 15, 2012 - 1:35pm
tags:
FDA, biosimilars, intellectual property
Teva scrambling toward post-Copaxone future
Fierce Pharma
Wednesday, February 15, 2012 - 1:33pm
tags:
Teva Pharmaceuticals, Copaxone
BioCryst jumps on hepatitis C study
Marketwatch
Wednesday, February 15, 2012 - 1:31pm
tags:
Biocryst, hepatitis C, BCX5191
Bionor Rises Most in 15 Months on AIDS Drug Study
Bloomberg
Wednesday, February 15, 2012 - 1:30pm
tags:
Bionor Pharma, HIV
Incyte Shares Decline After Fourth-Quarter Earnings
Bloomberg
Wednesday, February 15, 2012 - 1:29pm
tags:
earnings, Incyte

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.